The US FDA has cleared the first updates to the algorithm of the Omnipod 5 automated insulin delivery (AID) system (Insulet ...

Insulet has secured US Food and Drug Administration (FDA) clearance for an algorithm advancement within its Omnipod 5 ...

The FDA cleared an updated algorithm for a hybrid closed-loop insulin delivery system that permits users to set a lower ...

Insulet Corporation (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it has received FDA 510(k) clearance for ...

Insulet could be joining the competition to develop 'artificial pancreas' devices following the release of positive feasibility data for its solution. The Massachusetts-based company's 'hybrid ...

Torrey Pines High School. I’ve been living with Type 1 diabetes for over five years, and this weekend, I’ll be attending the ...

With an impeccable knowledge of multiple genres and a knack for skilful edits, the Liverpool collective create an unrivalled ...

Second-year receiver Adonai Mitchell, who arrived to the Jets via the Sauce Gardner deadline deal with the Colts last month, ...

Insulet (Nasdaq:PODD) today announced immediate compatibility between its Omnipod 5 system and the Dexcom (Nasdaq:DXCM) G7 15 ...

Growth stocks reflect firms on track for swift expansion, beating peers and the overall market. Their strategy to reinvest ...

December 4, 2025 Amsterdam, the Netherlands ? Royal Philips , a global leader in health technology, today reaffirmed that its 2026 outlook will be issued as planned on February 10, in line with the ...

Insulet’s stock price target has recently been raised, with the fair value estimate increasing from $366 to $378 following the company's Investor Day and updated outlook. This change reflects ...